Randomized Trial Comparing Safety of Remote Teleconsultation Versus Traditional Face-to-Face Clinical Follow-Up in Hospital Patients
Led by Consorci Sanitari de l'Alt Penedès i Garraf · Updated on 2026-10-27
2136
Participants Needed
3
Research Sites
21 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety of remote consultations, including video and telephone appointments, compared to traditional face-to-face consultations for patients in a hospital setting. This randomized controlled trial aims to assess whether remote follow-up is as safe as in-person visits by measuring complications related to the patients underlying diseases over a 12-month period. The study includes a total of 2136 patients randomly assigned to one of three groups face-to-face consultation, video consultation, or telephone consultation.
Participants will receive follow-up care through either in-person visits or remote consultations delivered by phone or video. Physicians will schedule at least three visits per participant a baseline screening visit, several intermediate visits based on medical need, and a final visit around 12 months after enrollment or earlier if the patient is discharged or discontinues early. Remote consultation patients will be reminded of appointments via text or call. Telephone consultations involve the doctor calling the patient or their family at the scheduled time, while video consultations use a secure application with a virtual waiting room.
During the study, participants will be monitored for complications, serious adverse events, avoidable hospitalizations, and unscheduled medical contacts. Researchers will also evaluate healthcare costs, usability of the video system, and satisfaction of both patients and health professionals with the care process. All interactions, including phone calls for control participants, will be recorded. The total participation duration is about 12 months, with physicians able to schedule or cancel appointments as needed throughout this period.
CONDITIONS
Brief Title
Open Label Randomized Clinical Trial to Assess the Safety of Teleconsultation
Research Team
A
Alejandro Rodríguez-Molinero, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Visual, hearing, or functional impairments affecting communication
Participation in another clinical trial requiring experimental intervention during follow-up
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
At least 1 baseline visit
Follow-up Visits
Duration - Up to 12 months
Participants receive scheduled follow-up visits either face-to-face or via remote consultation by phone or video. Physicians schedule intermediate visits as needed and a final visit around 12 months after enrollment or earlier if discharged or discontinued.
At least three visits including baseline, intermediate, and final visits
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Study protocol of a randomized controlled trial to assess safety of teleconsultation compared with face-to-face consultation: the ECASeT study.